What is Alkermes's change in deferred revenue?

Alkermes (ALKS) reported change in deferred revenue of $0 in Q4 2025.

How has Alkermes's change in deferred revenue changed year-over-year?

Alkermes's change in deferred revenue increased by 100.0% year-over-year, from -$1.09M to $0.

What is the long-term trend for Alkermes's change in deferred revenue?

Over 3 years (2021 to 2025), Alkermes's change in deferred revenue has grown at a -41.0% compound annual growth rate (CAGR), from -$6.08M to -$1.25M.

Alkermes ALKS Change in Deferred Revenue

Change in Deferred Revenue at other companies

Ionis PharmaceuticalsIONS

-$20.82M-51.8%

Arrowhead ResearchARWR

$163.36M—

BridgeBio PharmaBBIO

-$2.38M+7.5%

TG TherapeuticsTGTX

-$5.99M-4,377%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Free cash flow-$169.8M-291%

Valuation

See full

Market cap$7.5B+9.7%

Enterprise value$8.73B+41.2%

P/E49.1×+29.7×

P/S4.8×+0.3×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Alkermes’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alkermes's change in deferred revenue?: Alkermes (ALKS) reported change in deferred revenue of $0 in Q4 2025.
How has Alkermes's change in deferred revenue changed year-over-year?: Alkermes's change in deferred revenue increased by 100.0% year-over-year, from -$1.09M to $0.
What is the long-term trend for Alkermes's change in deferred revenue?: Over 3 years (2021 to 2025), Alkermes's change in deferred revenue has grown at a -41.0% compound annual growth rate (CAGR), from -$6.08M to -$1.25M.